11h agoNewLimit Completes Full Loop From Age Models To Rejuvenation AssaysD1 top authorOriginal postDEdelian@zebulgar@SinaHartung @jacobkimmel I’ve looked pretty broadly at this category. The differentiated thing isn’t just “longevity assets.” It’s that they've done full loop. Models of cell/organ age → large-scale mRNA TF payload screening → functional assays showing rejuvenation while preserving cell identity7:01 PM · Jun 3, 2026SentimentSentimentPos100%Neg0%Users praise NewLimit's progress from age models to rejuvenation assays for its compelling preclinical data and strong team, while noting the work remains preclinical.1 comment with sentiment. View comments.
